BUYER POOL ANALYSIS
Selling a Healthcare It to Private Equity / PE-Backed Roll-Up buyers
Private equity firms and PE-backed platform consolidators acquiring for roll-up, add-on, or platform plays. Pricing tends to lead the market for fee-viable scale, with multi-bidder competitive processes above the EBITDA floor.
Quick answers
- What multiple does this buyer pool pay?
- Median EV/EBITDA 18.35x across 40 disclosed deals (P25: 15.55x, P75: 23.61x). Median EV/Revenue 3.06x across 42 deals. Median deal value: $1000M.
- How many disclosed transactions?
- 61 deals total (61 from 2018+), filtered to Private Equity / PE-Backed Roll-Up acquirers of healthcare it businesses.
- Most active buyers
- TPG Capital (3) · Clearlake Capital Group, LP (3) · Bain Capital (2) · Advent International (2) · KKR (2) · Francisco Partners (2)
Recent disclosed deals
Private Equity / PE-Backed Roll-Up acquisitions of healthcare it businesses with named target, named acquirer, and disclosed financials.
| Year | Target | Acquirer | EV | EV/EBITDA | EV/Rev |
|---|---|---|---|---|---|
| 2026 | Optimum Healthcare IT, LLC | Infosys Limited | $465.0M | — | 1.69x |
| 2026 | Somatix, Inc. | Vitalist Inc. | $4.8M | — | 43.75x |
| 2025 | Aidéo Technologies LLC | Handson Global Management (HGM) Limited | $1.6M | — | 0.74x |
| 2025 | Carebook Technologies Inc | ICM Limited | $2.9M | — | 1.33x |
| 2025 | Forian Inc. | Oracle Investment Management, Inc. | $26.4M | — | 1.70x |
| 2025 | HealthEdge | Bain Capital | $2600.0M | 30.2x | 6.50x |
What this buyer pool prices for
Private equity acquirers price for scale and roll-up arbitrage. They pay up for businesses that fit a platform thesis — recurring revenue mix above 30%, technician/professional depth, clean financials, and a management layer that survives integration. The same healthcare it can command 1.5x to 2x the multiple of an individual-buyer transaction simply because the PE buyer is acquiring a platform piece, not an owner-operated shop.
Methodology note
Multiples shown are computed from disclosed M&A transactions in the ExitValue.ai database, filtered to healthcare it businesses acquired by private equity / pe-backed roll-up buyers. EV/EBITDA outliers outside the [0.5x, 60x] band and EV/Revenue outliers outside [0.05x, 25x] are excluded from medians. Where available, post-2018 transactions are weighted; otherwise the all-time sample is used. Deal counts shown reflect deals with disclosed financials only — total transaction count for this buyer pool is typically 2-3x larger. Full methodology
What's your healthcare it worth to private equity / pe-backed roll-up?
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Engine-grounded estimate. Comparable private equity / pe-backed roll-up deals on the full results page.